BDBM476494 (2S)-N-{[4-(aminomethyl)thiophen-2- yl]methyl}-4-(4,4-dimethyl-5-phenyl- 4,5-dihydro-1,3-oxazol-2-yl)-1- (N2,N2,N6,N6-tetramethyl-D- lysyl)piperazine-2-carboxamide::US10875851, Example 150

SMILES CN(C)CCCC[C@H](C(=O)N1CCN(C2=NC(C)(C)C(c3ccccc3)O2)C[C@H]1C(=O)NCc1cc(CN)cs1)N(C)C

InChI Key InChIKey=WOAXNMFFEYICTJ-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 476494   

TargetCoagulation factor XII(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 476494BDBM476494((2S)-N-{[4-(aminomethyl)thiophen-2- yl]methyl}-4-(...)
Affinity DataIC50: 48.5nMAssay Description:The effectiveness of a compound of the present invention as an inhibitor of Coagulation Factor XIIa can be determined using a relevant purified serin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
US Patent